22 Sep How Research Teams Ensure Doctor Meetings Remain Secure and Compliant
Research teams that conduct regular meetings with healthcare professionals (HCPs) are increasingly concerned about data safety and privacy as security risks rise. The U.S. Department of Health and Human Services’ Office for Civil Rights breach portal recorded more than 700 large healthcare data breaches in 2025, affecting approximately 62 million individuals. Risks can arise from meeting platforms, shared files, recordings, CRM integrations, and participant access. Organizations responsible for hosting, managing, or reviewing pharmaceutical- and research-related meetings must adopt key strategies to maintain security and compliance.
Photo by olia danilevich: https://www.pexels.com/photo/persons-using-laptops-on-table-with-charts-8145328/
The Dangers Posed by Shadow IT
IBM defines shadow IT as “any software, hardware, or information technology (IT) resource used on an enterprise network without the IT department’s approval, knowledge, or oversight.” In the medical research context, it develops when brands, research teams, or agencies purchase separate tools for meetings, congresses, webinars, and advisory boards. Examples of shadow IT include sharing work files on a personal cloud storage account, holding meetings through an unauthorized video conferencing platform when the company uses a different approved service, or creating an unofficial group chat without IT approval.
Using Company-Approved Platforms
The HIPAA Security Rule requires administrative, physical, and technical safeguards for electronic protected health information, including access controls and audit controls. To comply with this rule, pharmaceutical companies and other organizations are called upon to select and approve all meeting software. Ensuring that IT, security, legal, and compliance teams are involved from the start is key. Teams must vet software first and create a list of tools employees are allowed to use. Protocols must define who protects data, who deletes it when it becomes obsolete, who manages recordings and transcripts, who responds if information is lost or exposed, and where consent records are stored. All platforms must have identified internal owners, documented security requirements, specified data flows, retention rules, and incident-response processes. One single engagement platform with one identity spine and one data model covering congresses, webinars, advisory boards, and meetings may reduce the number of vendors that need to be reviewed.
Limiting Permissions
In addition to designating specific platforms for different types of meetings, organizations should configure their systems to limit the amount of information handled so as to reduce the impact of data breaches on both individual participants and their employers. Hosts should verify participants and grant role-based access so everyone involved — including participants, observers, and vendors — has only the permissions they strictly need. Using multi-factor authentication and promptly removing temporary or contractor access can also ensure compliance with HIPAA standards.
Protecting Data Throughout the Meeting Cycle
Before creating a registration form or opening a virtual room, it is vital to decide what information is genuinely required. Organizations should avoid collecting unnecessary contact details, recordings, or transcripts that can encroach on participants’ privacy. Participants should be informed about the data being collected and why it is necessary, and should provide consent for recording or other processes required by law. Additional measures include encrypting files, using strong authentication, and controlling download settings. Accurate records of what occurs at meetings — including material presented, scientific insights shared, and decisions and actions agreed upon — should be kept. For clinical trials, the FDA requires a secure, computer-generated, time-stamped record that allows reconstruction of any event that created, modified, or deleted an electronic record.
Choosing the Right Vendors
Platforms that connect to CRMs or other business systems create additional governance responsibilities. Before approving a vendor, pharmaceutical companies must request their system boundaries in writing. They should know the answers to questions such as where consent is stored, which platforms manage registration, and which system controls retention and deletion. SOC 2 or ISO 27001 certifications, or claims of HIPAA/GDPR compliance, should not be taken as sufficient evidence that all product configurations meet a company’s security requirements.
Building a Secure Foundation for HCP Meetings
The most secure doctor meetings are those in which each individual team does not have to invent its own process. Effective controls that ensure security and compliance include utilizing approved, vetted platforms, controlling data collection, and limiting permissions. Companies should establish strict protocols regarding roles and responsibilities, establish procedures to protect files and follow up, thoroughly review vendors, and clearly define system boundaries to avoid breaches and other costly mistakes.
For a broader overview of how healthcare organizations are approaching cybersecurity governance, HIPAA compliance, and vendor risk management across their digital infrastructure, see this MedicalResearch.com overview of healthcare technology priorities for clinical companies.
Disclaimer: The information on MedicalResearch.com is provided for educational purposes only, and is in no way intended to diagnose, cure, or treat any medical or other condition. Some links are sponsored. MedicalResearch.com and Eminent Domains Inc. do not warrant or endorse products or claims made by third party links. Always seek the advice of your physician or other qualified health provider and ask your doctor any questions you may have regarding a medical condition. In addition to all other limitations and disclaimers in this agreement, service provider and its third party providers disclaim any liability or loss in connection with the content provided on this website.
Last Updated on September 22, 2026 by Marie Benz MD FAAD